USE OF CISTANCHE TUBULOSA EXTRACT IN THE PREPARATION OF DRUGS OR FOODS FOR PROTECTING OCULAR CELLS

(19)

(11)

EP 3 181 143 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	18.11.2020 Bulletin 2020/47

(45)	Mention of the grant of the patent:
	23.09.2020 Bulletin 2020/39

(21)	Application number: 15814428.7

(22)	Date of filing: 03.07.2015

(51)

International Patent Classification (IPC):

A61K 36/896^(2006.01)
A61K 36/64^(2006.01)
A23L 5/00^(2016.01)
A61P 9/10^(2006.01)
A61P 27/06^(2006.01)

A61K 31/70^(2006.01)
A23L 33/105^(2016.01)
A61P 27/00^(2006.01)
A61P 27/02^(2006.01)

(86)	International application number:
	PCT/CN2015/083315

(87)	International publication number:
	WO 2016/000663 (07.01.2016 Gazette 2016/01)

(54)

USE OF CISTANCHE TUBULOSA EXTRACT IN THE PREPARATION OF DRUGS OR FOODS FOR PROTECTING OCULAR CELLS

VERWENDUNG VON CISTANCHE-TUBULOSA-EXTRAKT ZUR HERSTELLUNG VON ARZNEIMITTELN ODER NAHRUNGSMITTELN ZUM SCHUTZ VON AUGENZELLEN

APPLICATIONS DE L'EXTRAIT DE CISTANCHE TUBULOSA DANS LA PRÉPARATION D'UN MÉDICAMENT OU PRODUIT DE PROTECTION LES CELLULES DE L' IL

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA

(30)

Priority:

03.07.2014 US 201462020409 P

(43)	Date of publication of application:
	21.06.2017 Bulletin 2017/25

(73)	Proprietor: Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou)
	Yuhang Economic Development Zone Hangzhou Zhejiang 311100 (CN)

(72)	Inventor:
	LEE, Chin-wen Yilan Country 26994 (TW)

(74)	Representative: Boult Wade Tennant LLP
	Salisbury Square House 8 Salisbury Square London EC4Y 8AP London EC4Y 8AP (GB)

(56)

References cited: :

EP-A1- 2 792 361
WO-A1-2008/116391
CN-A- 1 526 400
CN-A- 103 896 997

WO-A1-01/34169
WO-A1-2012/158591
CN-A- 102 813 753
JP-A- 2013 023 487

DATABASE WPI Week 201446 Thomson Scientific, London, GB; AN 2014-J31623 XP002779634, & JP 2014 084319 A (DIABETYM CO LTD) 12 May 2014 (2014-05-12)
VENTURA L: "Introduction: Complementary medicine in ophthalmology", JOURNAL OF OCULAR BIOLOGY, DISEASES, AND INFORMATICS, SPRINGER-VERLAG, NEW YORK, vol. 2, no. 3, 31 August 2009 (2009-08-31) , pages 95-97, XP009504438, ISSN: 1936-8445, DOI: 10.1007/S12177-009-9029-3
NATALIA A STEFANOVA ET AL: "Effects of Cistanche deserticola on behavior and signs of cataract and retinopathy in senescence-accelerated OXYS rats", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 138, no. 2, 10 October 2011 (2011-10-10), pages 624-632, XP028112755, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2011.10.017 [retrieved on 2011-10-14]
JIANG Y ET AL: "Analysis of chemical constituents in Cistanche species", JOURNAL OF CHROMATOGRAPHY A, ELSEVIER, AMSTERDAM, NL, vol. 1216, no. 11, 13 March 2009 (2009-03-13), pages 1970-1979, XP025992515, ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2008.07.031 [retrieved on 2008-07-18]
SHENG, YANJUAN ET AL.: 'Research Progress in the Treatment of Age-Related Macular Degeneration' JOURNAL OF CLINICAL OPHTHALMOLOGY vol. 12, no. 5, 31 December 2004, pages 471 - 474, XP008185752
MOSCA, M. ET AL.: 'Ocular Tissue and Fluids Oxidative Stress in Hares Fed on Verbascoside' INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION vol. 65, no. 2, 31 March 2014, ISSN 0963-7486 pages 235 - 240, XP055250133

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).